Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals

Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals

Submitted by admin on October 12, 2020 - 10:28am
Source: 
Endpoints
News Tags: 
Eli Lilly
mirikizumab
Crohn's Disease
clinical trials
Headline: 
Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals
snippet: 

About a year and a half after presenting positive topline results in Crohn’s disease, Eli Lilly gave its experimental IL-23 anti-inflammatory mirikizumab a boost Monday with new data.

Do Not Allow Advertisers to Use My Personal information